Calcium-activated K + channels increase cell proliferation independent of K + conductance

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 4, 2011, Pages

  Millership, Joanne E ^a   Devor, Daniel C ^b   Hamilton, Kirk L ^c   Balut, Corina M ^b   Bruce, Jason I E ^a   Fearon, Ian M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ca 2+ influx; Cell proliferation; Intermediate conductance calcium activated potassium channel; Mitogen activated protein kinase

Indexed keywords

CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; FURA 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM ION; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IMMUNOPRECIPITATION; PATCH CLAMP; POTASSIUM CONDUCTANCE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CALCIUM; CELL MEMBRANE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE PROTEINS; PATCH-CLAMP TECHNIQUES; POTASSIUM; PYRAZOLES; SIGNAL TRANSDUCTION; SODIUM CHANNELS;

EID: 79955128038     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00274.2010     Document Type: Article

References (41)

1. Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol Gastrointest Liver Physiol 277: G631-G641, 1999.
2. Artym VV, Petty HR. Molecular proximity of KV1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol 120: 29-37, 2002.
3. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60: 1171-1178, 2000.
4. Boynton AL, Whitfield JF. Different calcium requirements for proliferation of conditionally and unconditionally tumorigenic mouse cells. Proc Nat Acad Sci USA 73: 1651-1654, 1976.
5. + channels in human T lymphocytes: a role in mitogenesis? Nature 307: 465-468, 1984.
6. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signalling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294: 333-339, 2001.
7. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 279: 11957-11966, 2004.
8. Ennis BW, Fultz KE, Smith KA, Westwick JK, Zhu D, Boluro-Ajayi M, Bilter GK, Stein B. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase. J Pharmacol Exp Ther 313: 325-332, 2005.
9. + channels are necessary for prolactin-induced proliferation in breast cancer cells. J Membrane Biol 234: 47-56, 2010.
10. + current in rat hippocampal neurons. Brain Res 920: 27-31, 2001.
11. Gelfand EW, Cheung RK, Mills GB, Grinstein S. Mitogens trigger a calcium-independent signal for proliferation in phorbol-ester-treated lymphocytes. Nature 315: 419-420, 1985.
12. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, Cahalan MD, Chandy KG. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 37137-37149, 2000.
13. + channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25: 704-709, 2005.
14. + channels. Proc Nat Acad Sci USA 103: 2886-2891, 2006.
15. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65: 630-638, 2004.
16. Jones HM, Bailey MA, Baty CJ, Macgregor GG, Syme CA, Hamilton KL, Devor DC. An NH2-terminal multi-basic RKR motif is required for the ATP-dependent regulation of hIK1. Channels (Austin) 1: 80-91, 2007.
17. + channel hIK1. J Biol Chem 279: 15531-15540, 2004.
18. Kaczmarek LK. Non-conducting functions of voltage-gated ion channels. Nat Rev Neurosci 7: 761-771, 2006.
19. Khiem D, Cyster JG, Schwarz JJ, Black BL. A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc Nat Acad Sci USA 105: 17067-17072, 2008.
20. Maher P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Biol Chem 274: 17491-17498, 1999.
21. + channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 287: C125-C134, 2004.
22. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Nat Acad Sci USA 90: 8319-8323, 1993.
23. + channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157-164, 2003.
24. Pedram A, Razandi M, Levin ER. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273: 26722-26728, 1998.
25. + channel function. Proc Nat Acad Sci USA 100: 7803-7807, 2003.
26. Preisig-Muller R, Schlichthorl G, Goerge T, Heinen S, Bruggemann A, Rajan S, Derst C, Veh RW, Daut J. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Nat Acad Sci USA 99: 7774-7779, 2002.
27. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001.
28. + channel, hIK1, is dependent upon a C-terminal leucine zipper. J Biol Chem 278: 8476-8486, 2003.
29. 2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol 295: C1409-C1416, 2008.
30. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 118: 3025-3037, 2008.
31. Uchida C, Gee E, Ispanovic E, Haas TL. JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 32: 769-776, 2008.
32. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Res 68: 1197-1203, 2008.
33. + channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62: 4843-4848, 2002.
34. + channel mediates B lymphoma cell cycle progression induced by serum. Pflügers Arch 454: 945-956, 2007.
35. Wang SP, Wang JA, Luo RH, Cui WY, Wang H. Potassium channel currents in rat mesenchymal stem cells and their possible roles in cell proliferation. Clin Exp Pharmacol Physiol 35: 1077-1084, 2008.
36. + channels inhibits progression of human endometrial cancer. Oncogene 26: 5107-5114, 2007.
37. Weng J, Cao Y, Moss N, Zhou M. Modulation of voltage-dependent Shaker family potassium channels by an aldo-keto reductase. J Biol Chem 281: 15194-15200, 2006.
38. Wulff H, Gutman GA, Cahalan MD, Chandy KG. Delineation of the clotrimazole/TRAM- 4 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem 276: 32040-32045, 2001.
39. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
40. Xue T, Marban E, Li RA. Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents by an engineered HCN1 construct: insights into structure-function relationships and multimerization. Circ Res 90: 1267-1273, 2002.
41. Zeng H, Fei H, Levitan IB. The slowpoke channel binding protein Slob from Drosophila melanogaster exhibits regulatable protein kinase activity. Neurosci Lett 365: 33-38, 2004.